Skip to main content

Multiplex Immunoassay Profiling of Serum in Psychiatric Disorders

  • Chapter
  • First Online:
Proteomic Methods in Neuropsychiatric Research

Part of the book series: Advances in Experimental Medicine and Biology ((PMISB,volume 974))

Abstract

Multiplex immunoassays allow for the rapid profiling of biomarker proteins in biological fluids, using less sample and labour than in single immunoassays. This chapter details the methods to develop and manufacture a 5-plex immunoassay for the Luminex® platform. Although assay development is not included here, the same methods can be used to covalently couple antibodies to the Luminex beads and to label antibodies for the screening of sandwich pairs, if needed. An example will be given for the analysis of five hormones (glucagon-like peptide 1, growth hormone, insulin, leptin and thyroid-stimulating hormone) in serum samples from schizophrenia patients and controls.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ryan MC, Thakore JH (2002) Physical consequences of schizophrenia and its treatment: the metabolic syndrome. Life Sci 71:239–257

    Article  CAS  PubMed  Google Scholar 

  2. Meyer JM, Davis VG, Goff DC, McEvoy JP, Nasrallah HA, Davis SM et al (2008) Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: prospective data from phase 1. Schizophr Res 101:273–286

    Article  PubMed  PubMed Central  Google Scholar 

  3. Spelman LM, Walsh PI, Sharifi N, Collins P, Thakore JH (2007) Impaired glucose tolerance in first-episode drug-naïve patients with schizophrenia. Diabet Med 24:481–485

    Article  CAS  PubMed  Google Scholar 

  4. Fulton RJ, McDade RL, Smith PL, Kienker LJ, Kettman JR Jr (1997) Advanced multiplexed analysis with the FlowMetrix system. Clin Chem 43:1749–1756

    CAS  PubMed  Google Scholar 

  5. Schwarz E, Guest PC, Rahmoune H, Harris LW, Wang L, Leweke FM et al (2012) Identification of a biological signature for schizophrenia in serum. Mol Psychiatry 17:494–502

    Article  CAS  PubMed  Google Scholar 

  6. Guest PC, Schwarz E, Krishnamurthy D, Harris LW, Leweke FM, Rothermundt M et al (2011) Altered levels of circulating insulin and other neuroendocrine hormones associated with the onset of schizophrenia. Psychoneuroendocrinology 36:1092–1096

    Article  CAS  PubMed  Google Scholar 

  7. Stephen L (2016) Multiplex immunoassay profiling. Methods Mol Biol 1546:169–176

    Article  Google Scholar 

  8. Todd DJ, Knowlton N, Amato M, Frank MB, Schur PH, Izmailova ES et al (2011) Erroneous augmentation of multiplex assay measurements in patients with rheumatoid arthritis due to heterophilic binding by serum rheumatoid factor. Arthritis Rheum 63:894–903

    Article  CAS  PubMed  Google Scholar 

  9. Fraser S, Soderstrom C (2014) Due diligence in the characterization of matrix effects in a total IL-13 Singulex™ method. Bioanalysis 6:1123–1129

    Article  CAS  PubMed  Google Scholar 

  10. Krika LJ (1999) Human anti-animal antibody interferences in immunological assays. Clin Chem 45:942–956

    Google Scholar 

  11. Jani D, Allinson J, Berisha F, Cowan KJ, Devanarayan V, Gleason C et al (2016) Recommendations for use and fit-for-purpose validation of biomarker multiplex ligand binding assays in drug development. AAPS J 18:1–14

    Article  CAS  PubMed  Google Scholar 

  12. Bastarache JA, Koyama Y, Wickersham NE, Ware LB (2014) Validation of a multiplex electrochemiluminescent immunoassay platform in human and mouse samples. J Immunol Methods 408:13–23

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Tighe PJ, Ryder RR, Todd I, Fairclough LC (2015) ELISA in the multiplex era: potentials and pitfalls. Proteomics Clin Appl 9:1862–8354

    Article  Google Scholar 

  14. Tighe P, Negm O, Todd I, Fairclough L (2013) Utility, reliability and reproducibility of immunoassay multiplex kits. Methods 61:23–29

    Article  CAS  PubMed  Google Scholar 

  15. Ellington AA, Kullo IJ, Bailey RK, Klee GG (2010) Antibody-based protein multiplex platforms: technical and operational challenges. Clin Chem 56:186–193

    Article  CAS  PubMed  Google Scholar 

  16. Spindel S, Sapsford KE (2014) Evaluation of optical detection platforms for multiplexed detection of proteins and the need for point-of-care biosensors for clinical use sensors. Sensors (Basel) 14:22313–22341

    Article  CAS  Google Scholar 

  17. Marquette CA, Corgier BP, Blum LJ (2012) Recent advances in multiplex immunoassays. Bioanalysis 4:927–936

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Laurie Stephen .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Stephen, L., Schwarz, E., Guest, P.C. (2017). Multiplex Immunoassay Profiling of Serum in Psychiatric Disorders. In: Guest, P. (eds) Proteomic Methods in Neuropsychiatric Research. Advances in Experimental Medicine and Biology(), vol 974. Springer, Cham. https://doi.org/10.1007/978-3-319-52479-5_10

Download citation

Publish with us

Policies and ethics